Results 1-1 of 1 (Search time: 0.001 seconds).
Start Date | Title | P-Investigator | Funding Organization/經費來源 |
---|---|---|---|
2012 | (100CAP020-2) In vivo Resistant Mechanisms of Sorafenib in Hepatocellular Carcinoma (HCC)---Development of Predictive Biomarkers and Resistance-Reversing Strategies (II) | CHIH-HUNG HSU | National Science and Technology Council |